Protalix BioTherapeutics
PLX
#8963
Rank
โ‚น17.79 B
Marketcap
โ‚น220.81
Share price
0.65%
Change (1 day)
74.10%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): โ‚น1.74

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is โ‚น1.91. In 2024 the company made an earnings per share (EPS) of โ‚น3.82 a decrease over its 2023 EPS that were of โ‚น11.45.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น1.74-54.27%
2024โ‚น3.82-66.67%
2023โ‚น11.45-138.71%
2022-โ‚น29.57-50%
2021-โ‚น59.14181.82%
2020-โ‚น20.98-82.11%
2019-โ‚น117.32-31.67%
2018-โ‚น171.69-72.31%
2017-โ‚น619.98124.14%
2016-โ‚น276.61-147.54%
2015โ‚น581.83-290.63%
2014-โ‚น305.226.67%
2013-โ‚น286.15130.77%
2012-โ‚น124.00-69.77%
2011-โ‚น410.1419.44%
2010-โ‚น343.38-12.2%
2009-โ‚น391.0736.67%
2008-โ‚น286.15-37.5%
2007-โ‚น457.8350%
2006-โ‚น305.223.23%
2005-โ‚น295.68138.46%
2004-โ‚น124.00-74%
2003-โ‚น476.91-0%
2002-โ‚น476.91-50%
2001-โ‚น953.82233.33%
2000-โ‚น286.15-84.21%
1999-โ‚น1,812-24%
1998-โ‚น2,385-600%
1997โ‚น476.91-16.67%
1996โ‚น572.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น124.95 6,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น640.01 33,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-โ‚น10.49-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น130.67 6,750.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel